Literature DB >> 10588599

Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample.

J J Hospers1, J P Schouten, S T Weiss, B Rijcken, D S Postma.   

Abstract

We studied the association between allergy defined as eosinophilia (>/= 275 cells/mm(3)) and/or positive skin tests (sum score >/= 3) and mortality from chronic obstructive pulmonary disease (COPD) after adjustment for major risk factors. In addition, we investigated this association in subgroups of respiratory symptoms and lung function. We used data from 7,556 participants of the respiratory surveys in 1964 -1972 in the general populations of Vlagtwedde, Vlaardingen, and Meppel (The Netherlands; mean age +/- SD: 39.3 yr +/- 14 in the 1960s). In 1995, the vital status was available (5,135 alive, 106 lost to follow-up, 121 primary deaths from COPD, and 2,194 other primary causes of which 137 had a secondary death cause from COPD. Positive skin tests were not associated with increased COPD mortality. The association between eosinophilia and COPD mortality was restricted to those who had reported asthma attacks and was present for both COPD as a primary cause (relative risk [RR] = 4.80; 95% confidence interval [CI] 1.9 to 11.9) and combined primary and secondary causes of death (RR = 3. 90; 95% CI 2.05 to 7.40). We conclude that eosinophilia with asthma attacks is a risk factor for COPD mortality in addition to known risk factors also found in our study such as male gender, older age, current smoking, low lung function, underweight, and dyspnea.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588599     DOI: 10.1164/ajrccm.160.6.9811041

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

1.  The Dutch hypothesis meets genomics.

Authors:  Scott T Weiss
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

Review 2.  Eosinophilic bronchitis: clinical manifestations and implications for treatment.

Authors:  P G Gibson; M Fujimura; A Niimi
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

3.  Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism.

Authors:  Qiong-Fang Yang; Ting-Ting Lu; Cai-Min Shu; Lan-Fang Feng; Hao-Teng Chang; Qiao-Ying Ji
Journal:  Exp Ther Med       Date:  2017-08-02       Impact factor: 2.447

4.  Asthma, airflow limitation and mortality risk in the general population.

Authors:  Shuang Huang; Monica M Vasquez; Marilyn Halonen; Fernando D Martinez; Stefano Guerra
Journal:  Eur Respir J       Date:  2014-10-16       Impact factor: 16.671

Review 5.  Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?

Authors:  Annelies Slats; Christian Taube
Journal:  Ther Adv Respir Dis       Date:  2015-11-22       Impact factor: 4.031

6.  The course of persistent airflow limitation in subjects with and without asthma.

Authors:  Stefano Guerra; Duane L Sherrill; Margaret Kurzius-Spencer; Claire Venker; Marilyn Halonen; Stuart F Quan; Fernando D Martinez
Journal:  Respir Med       Date:  2008-08-06       Impact factor: 3.415

7.  Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.

Authors:  Mona Bafadhel; Susan McKenna; Sarah Terry; Vijay Mistry; Mitesh Pancholi; Per Venge; David A Lomas; Michael R Barer; Sebastian L Johnston; Ian D Pavord; Christopher E Brightling
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

8.  Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.

Authors:  Eun Mi Chun; Seo Woo Kim; So Yeon Lim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-18

9.  Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?

Authors:  Cüneyt Saltürk; Zuhal Karakurt; Nalan Adiguzel; Feyza Kargin; Rabia Sari; M Emin Celik; Huriye Berk Takir; Eylem Tuncay; Ozlem Sogukpinar; Nezihe Ciftaslan; Ozlem Mocin; Gokay Gungor; Selahattin Oztas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-08

10.  The overlap phenotype: the (missing) link between asthma and COPD.

Authors:  Barbara Piras; Marc Miravitlles
Journal:  Multidiscip Respir Med       Date:  2012-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.